![]() SOPHiA GENETICS SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine. | ![]() Exscientia Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. | ![]() Genomic Health Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests. | Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. | ![]() Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy. | ![]() CellCarta CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory. | |
Founding Date | Founding Date 2011 | Founding Date 2012 | Founding Date 2000 | Founding Date 2008 | Founding Date 2012 | Founding Date 2001 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | ||||||
Locations | Locations Rolle, CH HQ Bidart, FR Boston, US | Locations Oxford, GB HQ Wien, AT Osaka, JP Dundee, GB Miami, US | Locations Redwood City, US HQ Köln, DE Chiyoda City, JP London, GB | Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US | Locations Redwood City, US HQ | Locations Antwerpen, BE HQ Berchem, BE Naperville, US |
Employees | Employees 423 | Employees 88 | Employees 311 | Employees 8154% increase | Employees 1,7681% decrease | Employees 4 |
Valuation ($) | Valuation ($) 236.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.6 b | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) $65.2m (FY, 2024) | Revenue (est.) £20.1m (FY, 2023) | Revenue (est.) $394.1m (FY, 2018) | Revenue (est.) $517.1m (FY, 2025) | Revenue (est.) $982m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $17.7m (FY, 2024) | Cost of goods £10.5m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods $349m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $47.6m (FY, 2024) | Gross profit £10.8m (FY, 2023) | Gross profit N/A | Gross profit $362.5m (FY, 2025) | Gross profit $633m (FY, 2025) | Gross profit N/A |
Net income | Net income ($62.5m) (FY, 2024) | Net income (£146m) (FY, 2023) | Net income $25.7m (FY, 2018) | Net income $66.4m (FY, 2025) | Net income ($416.3m) (FY, 2025) | Net income N/A |
Funding | ||||||
Total funding raised | Total funding raised $ 245.8m | Total funding raised $ 430.2m | Total funding raised N/A | Total funding raised $ 116.3m | Total funding raised $ 550m | Total funding raised N/A |

Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery.
View company
Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests.
View companyVeracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
View company
Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.
View company